Pal-ing, Jeneva M.

HRN: 26-79-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/21/2025
03/28/2025
PO
30ml
TID
SLE
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: